Dr. Olaf Hansen is a DVM (Doctor of Veterinary Medicine) from the University located in Hanover Germany with an MBA from Robert Kennedy College in Switzerland. Dr. Hansen is the Vice President of R&D (Research and Development) for Tevra Brands. Previously he was the Global Project Manager for Bayer Animal Health developing parasitic-ides. He is the founder of ConVet, an R&D company focusing on developing IP, intellectual property. Dr. Hansen holds 24 patents and continues to spend time and resources exploring and developing new products for Tevra Brands. Tevra Brands is very excited to have Dr Hansen share his knowledge and insights on our blog. He is an expert in parasitic-ides, or as we commonly call them flea and tick products, and the diseases they protect against. Dr. Hansen will provide insights to pet parents on what to apply and why, what the benefit of a topical flea and tick product is versus an oral solution, and why he felt it was important to provide veterinary quality formulations for the OTC (OTC) retail segment. Dr. Olaf Hansen helped developed and has his name on the Bayer K9 Advantix® II patent. He also developed Tevra Brands generic alternative to K9 Advantix II, which his name is on that patent as well. To learn more about Tevra® Brands and their products visit us at www.tevrabrands.com.
Please feel free to reach out to Dr. Hansen via the Tevra Brands Facebook page or email him at .